Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 12 |
GO:0042995 | cell projection | 2 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 12 |
Related structures:
AlphaFold database: E9AN05
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.408 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.478 |
CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.373 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.393 |
CLV_PCSK_SKI1_1 | 161 | 165 | PF00082 | 0.288 |
CLV_PCSK_SKI1_1 | 208 | 212 | PF00082 | 0.534 |
CLV_PCSK_SKI1_1 | 299 | 303 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 8 | 12 | PF00082 | 0.686 |
DEG_SCF_FBW7_1 | 283 | 288 | PF00400 | 0.491 |
DOC_ANK_TNKS_1 | 220 | 227 | PF00023 | 0.427 |
DOC_CDC14_PxL_1 | 89 | 97 | PF14671 | 0.345 |
DOC_CYCLIN_yCln2_LP_2 | 39 | 45 | PF00134 | 0.501 |
DOC_MAPK_gen_1 | 208 | 217 | PF00069 | 0.528 |
DOC_MAPK_MEF2A_6 | 11 | 19 | PF00069 | 0.543 |
DOC_MAPK_MEF2A_6 | 90 | 97 | PF00069 | 0.496 |
DOC_PP2B_LxvP_1 | 134 | 137 | PF13499 | 0.393 |
DOC_PP2B_PxIxI_1 | 14 | 20 | PF00149 | 0.565 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.672 |
DOC_USP7_MATH_1 | 323 | 327 | PF00917 | 0.530 |
DOC_USP7_UBL2_3 | 331 | 335 | PF12436 | 0.540 |
DOC_USP7_UBL2_3 | 4 | 8 | PF12436 | 0.721 |
DOC_WW_Pin1_4 | 281 | 286 | PF00397 | 0.435 |
LIG_14-3-3_CanoR_1 | 154 | 160 | PF00244 | 0.427 |
LIG_14-3-3_CanoR_1 | 299 | 305 | PF00244 | 0.495 |
LIG_Actin_WH2_2 | 260 | 276 | PF00022 | 0.467 |
LIG_Actin_WH2_2 | 80 | 98 | PF00022 | 0.386 |
LIG_APCC_ABBA_1 | 70 | 75 | PF00400 | 0.376 |
LIG_EH_1 | 126 | 130 | PF12763 | 0.392 |
LIG_FHA_1 | 158 | 164 | PF00498 | 0.344 |
LIG_FHA_1 | 286 | 292 | PF00498 | 0.444 |
LIG_FHA_1 | 301 | 307 | PF00498 | 0.312 |
LIG_FHA_1 | 308 | 314 | PF00498 | 0.460 |
LIG_LIR_Nem_3 | 118 | 123 | PF02991 | 0.514 |
LIG_LIR_Nem_3 | 165 | 169 | PF02991 | 0.307 |
LIG_LIR_Nem_3 | 191 | 197 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 41 | 46 | PF02991 | 0.473 |
LIG_LYPXL_yS_3 | 92 | 95 | PF13949 | 0.326 |
LIG_PCNA_yPIPBox_3 | 154 | 163 | PF02747 | 0.427 |
LIG_SH2_CRK | 120 | 124 | PF00017 | 0.542 |
LIG_SH2_CRK | 194 | 198 | PF00017 | 0.342 |
LIG_SH2_CRK | 315 | 319 | PF00017 | 0.510 |
LIG_SH2_STAT5 | 148 | 151 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.486 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.342 |
LIG_SH3_3 | 39 | 45 | PF00018 | 0.501 |
LIG_SH3_3 | 63 | 69 | PF00018 | 0.406 |
LIG_SUMO_SIM_anti_2 | 107 | 115 | PF11976 | 0.423 |
LIG_SUMO_SIM_anti_2 | 212 | 219 | PF11976 | 0.455 |
LIG_SUMO_SIM_par_1 | 107 | 115 | PF11976 | 0.373 |
LIG_SUMO_SIM_par_1 | 258 | 265 | PF11976 | 0.469 |
LIG_SUMO_SIM_par_1 | 317 | 322 | PF11976 | 0.418 |
LIG_TYR_ITIM | 192 | 197 | PF00017 | 0.323 |
LIG_TYR_ITIM | 313 | 318 | PF00017 | 0.532 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.436 |
MOD_CK1_1 | 185 | 191 | PF00069 | 0.402 |
MOD_CK1_1 | 213 | 219 | PF00069 | 0.427 |
MOD_CK1_1 | 307 | 313 | PF00069 | 0.538 |
MOD_CK2_1 | 238 | 244 | PF00069 | 0.502 |
MOD_CK2_1 | 283 | 289 | PF00069 | 0.517 |
MOD_Cter_Amidation | 328 | 331 | PF01082 | 0.570 |
MOD_Cter_Amidation | 333 | 336 | PF01082 | 0.620 |
MOD_Cter_Amidation | 5 | 8 | PF01082 | 0.645 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.650 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.513 |
MOD_GlcNHglycan | 321 | 324 | PF01048 | 0.508 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.381 |
MOD_GSK3_1 | 182 | 189 | PF00069 | 0.397 |
MOD_GSK3_1 | 279 | 286 | PF00069 | 0.442 |
MOD_GSK3_1 | 291 | 298 | PF00069 | 0.357 |
MOD_GSK3_1 | 300 | 307 | PF00069 | 0.465 |
MOD_GSK3_1 | 319 | 326 | PF00069 | 0.384 |
MOD_N-GLC_1 | 155 | 160 | PF02516 | 0.310 |
MOD_N-GLC_1 | 183 | 188 | PF02516 | 0.294 |
MOD_N-GLC_1 | 213 | 218 | PF02516 | 0.427 |
MOD_N-GLC_2 | 279 | 281 | PF02516 | 0.406 |
MOD_NEK2_1 | 248 | 253 | PF00069 | 0.382 |
MOD_NEK2_1 | 291 | 296 | PF00069 | 0.392 |
MOD_PIKK_1 | 323 | 329 | PF00454 | 0.582 |
MOD_PKA_2 | 304 | 310 | PF00069 | 0.494 |
MOD_Plk_1 | 155 | 161 | PF00069 | 0.307 |
MOD_Plk_1 | 183 | 189 | PF00069 | 0.310 |
MOD_Plk_1 | 213 | 219 | PF00069 | 0.399 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.462 |
MOD_Plk_4 | 213 | 219 | PF00069 | 0.455 |
MOD_ProDKin_1 | 281 | 287 | PF00069 | 0.428 |
MOD_SUMO_for_1 | 50 | 53 | PF00179 | 0.394 |
MOD_SUMO_rev_2 | 75 | 84 | PF00179 | 0.365 |
TRG_DiLeu_BaEn_1 | 34 | 39 | PF01217 | 0.241 |
TRG_ENDOCYTIC_2 | 120 | 123 | PF00928 | 0.471 |
TRG_ENDOCYTIC_2 | 194 | 197 | PF00928 | 0.323 |
TRG_ENDOCYTIC_2 | 315 | 318 | PF00928 | 0.432 |
TRG_ENDOCYTIC_2 | 92 | 95 | PF00928 | 0.326 |
TRG_ER_diArg_1 | 29 | 31 | PF00400 | 0.407 |
TRG_ER_diArg_1 | 48 | 50 | PF00400 | 0.441 |
TRG_ER_diLys_1 | 333 | 338 | PF00400 | 0.671 |
TRG_NLS_MonoCore_2 | 329 | 334 | PF00514 | 0.539 |
TRG_NLS_MonoExtC_3 | 330 | 335 | PF00514 | 0.510 |
TRG_NLS_MonoExtN_4 | 330 | 336 | PF00514 | 0.543 |
TRG_Pf-PMV_PEXEL_1 | 30 | 34 | PF00026 | 0.381 |
TRG_Pf-PMV_PEXEL_1 | 48 | 53 | PF00026 | 0.498 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBA8 | Leptomonas seymouri | 70% | 100% |
A0A0S4JEI1 | Bodo saltans | 39% | 90% |
A0A1X0NI28 | Trypanosomatidae | 46% | 100% |
A0A1X0P364 | Trypanosomatidae | 25% | 79% |
A0A3R7L7Y9 | Trypanosoma rangeli | 26% | 76% |
A0A3R7N0J2 | Trypanosoma rangeli | 45% | 100% |
A0A3S5H6F0 | Leishmania donovani | 95% | 100% |
A0A3S7WZL6 | Leishmania donovani | 24% | 79% |
A0JPI9 | Rattus norvegicus | 21% | 71% |
A4H5X9 | Leishmania braziliensis | 86% | 100% |
A4HU75 | Leishmania infantum | 95% | 100% |
A4I1Y5 | Leishmania infantum | 24% | 79% |
C9ZS33 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 75% |
D0A9Q7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9ADA9 | Leishmania major | 25% | 85% |
E9AY32 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 71% |
E9AZ34 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 85% |
P10775 | Sus scrofa | 28% | 74% |
Q4QHM3 | Leishmania major | 95% | 100% |
V5BDE5 | Trypanosoma cruzi | 45% | 98% |